Zenlabs Ethica Ltd
ZENLABSZenlabs Ethica Ltd
ZENLABS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 71.18 | 2.74 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Zenlabs Ethica, formerly Neelkanth Technologies Limited, is a pharmaceutical company engaged in trading/marketing in pharmaceutical products
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.00 | 81.24 | 71.94 | 67.46 | 60.00 | 56.76 | 69.18 | 67.02 | 58.86 | 57.61 | ||||||||||
Raw Materials | 20.19 | 63.38 | 52.79 | 54.72 | 49.61 | 47.31 | 59.86 | 56.02 | 44.41 | 54.86 | ||||||||||
| Power & Fuel Cost | 0.01 | 0.03 | 0.02 | 0.03 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 | |||||||||||
| Employee Cost | 0.69 | 3.05 | 2.80 | 3.28 | 3.24 | 3.42 | 3.90 | 4.33 | 4.46 | |||||||||||
| Selling & Administrative Expenses | 2.86 | 10.60 | 9.03 | 8.98 | 7.56 | 4.42 | 6.13 | 6.14 | 7.53 | |||||||||||
| Operating & Other expenses | -7.91 | 2.65 | 5.35 | -1.74 | 0.20 | -0.30 | -3.24 | -1.96 | -0.29 | |||||||||||
EBITDA | 0.16 | 1.53 | 1.95 | 2.19 | -0.65 | 1.86 | 2.49 | 2.46 | 2.71 | 2.75 | ||||||||||
| Depreciation/Amortization | 0.06 | 0.20 | 0.20 | 0.23 | 0.29 | 0.71 | 0.89 | 1.25 | 1.29 | 1.29 | ||||||||||
| PBIT | 0.10 | 1.33 | 1.75 | 1.96 | -0.94 | 1.15 | 1.60 | 1.21 | 1.42 | 1.46 | ||||||||||
| Interest & Other Items | 0.02 | 0.10 | 0.09 | 0.07 | 0.23 | 0.29 | 0.37 | 0.53 | 0.83 | 0.91 | ||||||||||
| PBT | 0.08 | 1.23 | 1.66 | 1.89 | -1.17 | 0.86 | 1.23 | 0.68 | 0.59 | 0.55 | ||||||||||
| Taxes & Other Items | -0.08 | 0.27 | 0.49 | 0.62 | -0.43 | 0.09 | 0.44 | 0.18 | 0.16 | 0.16 | ||||||||||
| Net Income | 0.16 | 0.96 | 1.17 | 1.27 | -0.74 | 0.77 | 0.79 | 0.50 | 0.43 | 0.39 | ||||||||||
| EPS | 0.31 | 1.47 | 1.80 | 1.95 | -1.14 | 1.18 | 1.21 | 0.77 | 0.66 | 0.60 | ||||||||||
| DPS | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenlabs Ethica Ltd | 64.56 | 2.74 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare ZENLABS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 29, 2022
Dividend/Share
₹0.25
Ex DateEx Date
Jul 29, 2022
Cash Dividend
Ex DateEx DateSep 20, 2017
Dividend/Share
₹0.25
Ex DateEx Date
Sep 20, 2017
Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Zenlabs Ethica declined 42.86% to Rs 0.04 crore in the quarter ended June 2024 as against Rs 0.07 crore during the previous quarter ended June 2023. Sales declined 8.92% to Rs 12.36 crore in the quarter ended June 2024 as against Rs 13.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.3613.57 -9 OPM %5.023.91 - PBDT0.390.42 -7 PBT0.070.10 -30 NP0.040.07 -43 Powered by Capital Market - Live
Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Zenlabs Ethica Standalone March 2023 Net Sales at Rs 14.60 crore, up 1.23% Y-o-Y
Zenlabs Ethica standalone net profit rises 64.00% in the September 2022 quarter
Upcoming dividend stocks: 6 stocks to turn ex-dividend tomorrow
Zenlabs Ethica Standalone March 2022 Net Sales at Rs 14.43 crore, up 4.62% Y-o-Y
Zenotech Laboratories standalone net profit rises 5057.14% in the December 2021 quarter
Zenlabs Ethica standalone net profit rises 25.00% in the September 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -2.69%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.03% to 0.02%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -19.47%, vs industry avg of 15.28%